Trytosaveabit commented on a stock · Jul 16 07:38

Update

$Hoth Therapeutics(HOTH.US)$ Hoth Therapeutics Approved To Proceed With First-In-Human Phase 2a Clinical Trial Of HT-001 For Treatment Of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Benzinga· 3 mins ago

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

1028 Views

Comment

Trytosaveabit

2503Followers

28Following

33KVisitors